These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31850678)

  • 1. Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.
    Bernstock JD; Alva E; Cohen JL; Lobbous M; Chagoya G; Elsayed GA; Orr BA; Rozzelle C; Rocque B; Blount J; Johnston JM; Li R; Fiveash JB; Dhall G; Reddy AT; Friedman GK
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28119. PubMed ID: 31850678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
    Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
    Kim H; Kang HJ; Lee JW; Park JD; Park KD; Shin HY; Ahn HS
    Childs Nerv Syst; 2013 Oct; 29(10):1851-8. PubMed ID: 23748464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of high-dose chemotherapy protocols to treat infants with malignant central nervous system tumors: Experience from a middle-income country.
    Elshahoubi A; Khattab E; Halalsheh H; Khaleifeh K; Bouffet E; Amayiri N
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27464. PubMed ID: 30251335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
    J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
    Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.
    Fouladi M; Gururangan S; Moghrabi A; Phillips P; Gronewold L; Wallace D; Sanford RA; Gajjar A; Kun LE; Heideman R
    Cancer; 2009 Jul; 115(14):3243-53. PubMed ID: 19484793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Park ES; Sung KW; Baek HJ; Park KD; Park HJ; Won SC; Lim DH; Kim HS
    J Korean Med Sci; 2012 Feb; 27(2):135-40. PubMed ID: 22323859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
    Finkelstein-Shechter T; Gassas A; Mabbott D; Huang A; Bartels U; Tabori U; Janzen L; Hawkins C; Taylor M; Bouffet E
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):e182-6. PubMed ID: 20495479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.